Attovia Therapeutics, Inc.ATTO
Key ratios
FCF / Sales
-3790.2%TTM
2025
-4556.4%
ROA
-34.6%2025
ROE
-57.0%TTM
2025
-57.0%
Recent news
Attovia Therapeutics to Participate in Upcoming Investor Conferences
Attovia Therapeutics Announces Pricing of Upsized Initial Public Offering
Track ATTO in your journal
Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.
Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer